Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma.

ABSTRACT:

Background

Prostate-specific membrane antigen (PSMA) is overexpressed in the neovasculature of renal cell carcinoma (RCC). However, there remains limited evidence regarding the use of PSMA positron emission tomography/computed tomography (PET/CT) in RCC.

Objective

To assess the impact of PSMA PET/CT in the management of metastatic RCC.

Design setting and participants

This was a retrospective review of patients who underwent PSMA PET/CT from 2014 to 2020 for restaging or suspected metastatic RCC in a tertiary academic setting.

Outcome measurements and statistical analysis

Management plans before and after PSMA PET/CT were recorded. Impact was classified as high (change of treatment intent, modality, or site), medium (change in treatment method), or low. Secondar

SUBMITTER: Udovicich C 

PROVIDER: S-EPMC9520507 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature